Home › Calculator › BOLT Dividend Calculator 2026
BOLT Dividend Calculator 2026
No dividendHealthcareBolt Biotherapeutics, Inc. · NASDAQ
Price: $6.27 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
BOLT is not a dividend-focused stock
BOLT pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
BOLT Dividend Yield
Bolt Biotherapeutics, Inc. (BOLT) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BOLT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Bolt Biotherapeutics, Inc. (BOLT) — Dividend Analysis 2026
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indications such as colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody designed to reprogram crucial immune cells within the tumor microenvironment by interacting with macrophage cell-surface receptors. Bolt is also pursuing a programmed cell death-ligand 1 (PD-L1) initiative aimed at addressing tumors that prove resistant to existing immune checkpoint blockades. Incorporated in 2015 under its previous name, Bolt Therapeutics, Inc., before officially becoming Bolt Biotherapeutics, Inc. in July of the same year, the company maintains its corporate headquarters in Redwood City, California.
BOLT Dividend & DRIP — Frequently Asked Questions
Does BOLT pay a dividend?
No. Bolt Biotherapeutics, Inc. (BOLT) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of BOLT?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does BOLT have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. BOLT has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to BOLT
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BOLT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BOLT position with:
🌍 BOLT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BOLT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BOLT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BOLT Dividend Payment Schedule
BOLT pays quarterly — 4 times per year. Ex-div: —.
📊 BOLT vs Healthcare Benchmarks
How BOLT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BOLT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BOLT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-09-16 | 1,417 | $3.77 | $5.3K | ||
| Sale | 2026-09-17 | 4,909 | $3.32 | $16.3K | ||
| Sale | 2026-09-18 | 6,850 | $3.24 | $22.2K | ||
| Sale | 2026-09-16 | 843 | $3.77 | $3.2K | ||
| Sale | 2026-09-17 | 2,922 | $3.32 | $9.7K | ||
| Sale | 2026-09-18 | 4,077 | $3.24 | $13.2K | ||
| Buy | 2026-06-05 | 509 | $3.88 | $2.0K | ||
| Sale | 2026-09-16 | 1,889 | $3.77 | $7.1K | ||
| Sale | 2026-09-17 | 6,545 | $3.32 | $21.7K | ||
| Sale | 2026-09-18 | 9,132 | $3.24 | $29.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare BOLT with peers: BOLT vs AEON · BOLT vs CING · BOLT vs CLRB
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BOLT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Bolt Biotherapeutics, Inc. (BOLT) is currently trading at $6.27, 19% below its 52-week high. It does not currently pay a regular dividend.
Does BOLT Pay a Dividend? Bolt Biotherapeutics, Inc. Dividend Status
Bolt Biotherapeutics, Inc. (BOLT) is a healthcare stock trading at $6.27. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BOLT News
LiveProjected your BOLT DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.